USA GABA (Gamma-Aminobutyric Acid) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • GAMMA-Aminobutyric acid, or ?-aminobutyric acid or GABA, is the chief inhibitory neurotransmitter in the mammalian central nervous system.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA GABA (Gamma-Aminobutyric Acid) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA GABA (Gamma-Aminobutyric Acid) market. Detailed analysis of key players, along with key growth strategies adopted by GABA (Gamma-Aminobutyric Acid) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Novartis

    • Ovation Pharmaceuticals

    • Pfizer

    • Sanofi

    • Vivus

    • Astrazeneca

    • Elan

    • Eli Lilly

    • Glaxosmithkline

    By Type:

    • Chemical Synthesis

    • Biological Fermentation

    By End-User:

    • Pharmaceuticals

    • Foods

    • Beverages

    • Feeds Industries

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of GABA (Gamma-Aminobutyric Acid) Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Chemical Synthesis from 2016 to 2027

      • 1.3.2 USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Biological Fermentation from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Pharmaceuticals from 2016 to 2027

      • 1.4.2 USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Foods from 2016 to 2027

      • 1.4.3 USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Beverages from 2016 to 2027

      • 1.4.4 USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Feeds Industries from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA GABA (Gamma-Aminobutyric Acid) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA GABA (Gamma-Aminobutyric Acid) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of GABA (Gamma-Aminobutyric Acid) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of GABA (Gamma-Aminobutyric Acid) by Major Types

      • 3.4.1 Market Size and Growth Rate of Chemical Synthesis

      • 3.4.2 Market Size and Growth Rate of Biological Fermentation

    4 Segmentation of GABA (Gamma-Aminobutyric Acid) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of GABA (Gamma-Aminobutyric Acid) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of GABA (Gamma-Aminobutyric Acid) in Pharmaceuticals

      • 4.4.2 Market Size and Growth Rate of GABA (Gamma-Aminobutyric Acid) in Foods

      • 4.4.3 Market Size and Growth Rate of GABA (Gamma-Aminobutyric Acid) in Beverages

      • 4.4.4 Market Size and Growth Rate of GABA (Gamma-Aminobutyric Acid) in Feeds Industries

    5 Market Analysis by Regions

    • 5.1 USA GABA (Gamma-Aminobutyric Acid) Production Analysis by Regions

    • 5.2 USA GABA (Gamma-Aminobutyric Acid) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis

    • 6.1 West USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis by Major Types

    • 6.2 West USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis by Major End-Users

    7 South USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis

    • 7.1 South USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis by Major Types

    • 7.2 South USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis by Major End-Users

    8 Middle West USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis

    • 8.1 Middle West USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis by Major Types

    • 8.2 Middle West USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis by Major End-Users

    9 Northeast USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis

    • 9.1 Northeast USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis by Major Types

    • 9.2 Northeast USA GABA (Gamma-Aminobutyric Acid) Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Novartis

        • 10.1.1 Novartis Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Ovation Pharmaceuticals

        • 10.2.1 Ovation Pharmaceuticals Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Pfizer

        • 10.3.1 Pfizer Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Sanofi

        • 10.4.1 Sanofi Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Vivus

        • 10.5.1 Vivus Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Astrazeneca

        • 10.6.1 Astrazeneca Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Elan

        • 10.7.1 Elan Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Eli Lilly

        • 10.8.1 Eli Lilly Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Glaxosmithkline

        • 10.9.1 Glaxosmithkline Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Chemical Synthesis from 2016 to 2027

    • Figure USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Biological Fermentation from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Pharmaceuticals from 2016 to 2027

    • Figure USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Foods from 2016 to 2027

    • Figure USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Beverages from 2016 to 2027

    • Figure USA GABA (Gamma-Aminobutyric Acid) Market Size and Growth Rate of Feeds Industries from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA GABA (Gamma-Aminobutyric Acid) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA GABA (Gamma-Aminobutyric Acid) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of GABA (Gamma-Aminobutyric Acid) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of GABA (Gamma-Aminobutyric Acid)

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of GABA (Gamma-Aminobutyric Acid) by Different Types from 2016 to 2027

    • Table Consumption Share of GABA (Gamma-Aminobutyric Acid) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Chemical Synthesis

    • Figure Market Size and Growth Rate of Biological Fermentation

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of GABA (Gamma-Aminobutyric Acid) by Different End-Users from 2016 to 2027

    • Table Consumption Share of GABA (Gamma-Aminobutyric Acid) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Pharmaceuticals

    • Figure Market Size and Growth Rate of Foods

    • Figure Market Size and Growth Rate of Beverages

    • Figure Market Size and Growth Rate of Feeds Industries

    • Table USA GABA (Gamma-Aminobutyric Acid) Production by Regions

    • Table USA GABA (Gamma-Aminobutyric Acid) Production Share by Regions

    • Figure USA GABA (Gamma-Aminobutyric Acid) Production Share by Regions in 2016

    • Figure USA GABA (Gamma-Aminobutyric Acid) Production Share by Regions in 2021

    • Figure USA GABA (Gamma-Aminobutyric Acid) Production Share by Regions in 2027

    • Table USA GABA (Gamma-Aminobutyric Acid) Consumption by Regions

    • Table USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Regions

    • Figure USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Regions in 2016

    • Figure USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Regions in 2021

    • Figure USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Regions in 2027

    • Table West USA GABA (Gamma-Aminobutyric Acid) Consumption by Types from 2016 to 2027

    • Table West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types from 2016 to 2027

    • Figure West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2016

    • Figure West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2021

    • Figure West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2027

    • Table West USA GABA (Gamma-Aminobutyric Acid) Consumption by End-Users from 2016 to 2027

    • Table West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users from 2016 to 2027

    • Figure West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2016

    • Figure West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2021

    • Figure West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2027

    • Table South USA GABA (Gamma-Aminobutyric Acid) Consumption by Types from 2016 to 2027

    • Table South USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types from 2016 to 2027

    • Figure South USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2016

    • Figure South USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2021

    • Figure South USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2027

    • Table South USA GABA (Gamma-Aminobutyric Acid) Consumption by End-Users from 2016 to 2027

    • Table South USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users from 2016 to 2027

    • Figure South USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2016

    • Figure South USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2021

    • Figure South USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2027

    • Table Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption by Types from 2016 to 2027

    • Table Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2016

    • Figure Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2021

    • Figure Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2027

    • Table Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption by End-Users from 2016 to 2027

    • Table Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2016

    • Figure Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2021

    • Figure Middle West USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2027

    • Table Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption by Types from 2016 to 2027

    • Table Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2016

    • Figure Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2021

    • Figure Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Share by Types in 2027

    • Table Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption by End-Users from 2016 to 2027

    • Table Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2016

    • Figure Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2021

    • Figure Northeast USA GABA (Gamma-Aminobutyric Acid) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Ovation Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ovation Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ovation Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ovation Pharmaceuticals

    • Table Product and Service Introduction of Ovation Pharmaceuticals

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Vivus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vivus

    • Figure Sales and Growth Rate Analysis of Vivus

    • Figure Revenue and Market Share Analysis of Vivus

    • Table Product and Service Introduction of Vivus

    • Table Company Profile and Development Status of Astrazeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca

    • Figure Sales and Growth Rate Analysis of Astrazeneca

    • Figure Revenue and Market Share Analysis of Astrazeneca

    • Table Product and Service Introduction of Astrazeneca

    • Table Company Profile and Development Status of Elan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elan

    • Figure Sales and Growth Rate Analysis of Elan

    • Figure Revenue and Market Share Analysis of Elan

    • Table Product and Service Introduction of Elan

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Glaxosmithkline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glaxosmithkline

    • Figure Sales and Growth Rate Analysis of Glaxosmithkline

    • Figure Revenue and Market Share Analysis of Glaxosmithkline

    • Table Product and Service Introduction of Glaxosmithkline


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.